Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE1
200 participants
INTERVENTIONAL
2004-06-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer Prevention and Care Among Aged
NCT01831375
Translating Healthy Lifestyle Interventions for Cancer Survivors
NCT02690766
Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention
NCT04826315
Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
NCT02337452
Patient-caregiver Communication Intervention for Prognostic Understanding
NCT03833817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Information
Preventive Services
Computer tailored information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has type 2 (adult-onset) diabetes;
* Developed diabetes after the age of 21;
* Has a scheduled doctor visit about diabetes in the next few months
21 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Jefferson University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher N Sciamanna, MD
Role: STUDY_CHAIR
Thomas Jefferson Unversity
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K07-CA91976-0
Identifier Type: -
Identifier Source: secondary_id
04F.244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.